<html><head><link rel="stylesheet" href="https://unpkg.com/mvp.css"></head><title>CCI approves the proposal of Tau Investment to acquire shares in J B Chemicals</title><body><h1>CCI approves the proposal of Tau Investment to acquire shares in J B Chemicals</h1><p style="text-align:justify">The Competition Commission of India (CCI) approves the proposal of Tau Investment to acquire shares in J B Chemicals. The proposed combination envisages acquisition of acquisition of up to 64.90% of share capital of J B Chemicals &#038; Pharmaceuticals Limited by Tau Investment Holdings Pte. Ltd. (Tau Investment).</p>
<p style="text-align:justify"> </p>
<p style="text-align:justify">Tau Investment is a company incorporated in Singapore. It is an indirect wholly owned subsidiary of KKR Asian Fund III L.P. It is an affiliate of funds, vehicles and/or entities managed and/or advised by Kohlberg Kravis Roberts &#038; Co. L.P., which is an indirect subsidiary of KKR &#038; Co. Inc.</p>
<p style="text-align:justify">J B Chemicals &#038; Pharmaceuticals Limited is an Indian pharmaceutical company, headquartered in Mumbai, Maharashtra. It is listed on BSE Limited and the National Stock Exchange of India Limited.</p>
<p style="text-align:justify"> </p>
<p style="text-align:justify">Detailed order of the CCI will follow.</p>
<p style="text-align:justify">
</body></html>